TLR9 and psoriasis: Recent publications demonstrated that the anti-microbial peptide LL-37 isolated from psoriasis skin lesions can bind eukaryotic DNA and RNA and trigger peripheral blood pDC to secrete IFN-α in a TLR-9 dependent manner [29], [30].